Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Symptomatic treatment in multiple sclerosis-interim analysis of a nationwide registry.
Immunologic profiles of multiple sclerosis treatments reveal shared early B cell alterations.
PRDX6 controls multiple sclerosis by suppressing inflammation and blood brain barrier disruption.
Medical marijuana patient counseling points for health care professionals based on trends in the medical uses, efficacy, and adverse effects of cannabis-based pharmaceutical drugs.
The importance of a multi-disciplinary perspective and patient activation programmes in MS management.
SIRT1 and NAD+ precursors: Therapeutic targets in multiple sclerosis a review.
Myelin Avoids the JAM.
Detection of Thyroid Abnormalities in Aquaporin-4 Antibody-Seropositive Optic Neuritis Patients.
The use of clinically approved small particles of iron oxide (SPIO) for labeling of mesenchymal stem cells aggravates clinical symptoms in experimental autoimmune encephalomyelitis and influences their in vivo distribution.
Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis.
Paediatric brainstem: A comprehensive review of pathologies on MR imaging.
Overview and diagnosis of multiple sclerosis.
Predictors of static balance in ambulatory persons with multiple sclerosis.
Cre inducible site-specific recombination in zebrafish oligodendrocytes.
In-depth cerebrospinal fluid quantitative proteome and deglycoproteome analysis; presenting a comprehensive picture of pathways and processes affected by multiple sclerosis.
Vaccination with DNA encoding an immunodominant myelin basic protein peptide targeted to Fc of immunoglobulin G suppresses experimental autoimmune encephalomyelitis.
In Vivo 7T MR Quantitative Susceptibility Mapping Reveals Opposite Susceptibility Contrast between Cortical and White Matter Lesions in Multiple Sclerosis.
Serum Vitamin B12 and thyroid hormone levels in Saudi patients with multiple sclerosis.
Persistency, medication prescribing patterns, and medical resource use associated with multiple sclerosis patients receiving oral disease-modifying therapies: a retrospective medical record review.
Physical Activity and Its Correlates in Youth with Multiple Sclerosis.
Differentiation of bone marrow stromal cells into schwann-like cells using dihydrotestosterone combined with a classical induction method.
Considerations in the development of generic disease therapies for multiple sclerosis.
Nogo-A does not inhibit retinal axon regeneration in the lizard, Gallotia galloti.
Active immunotherapy may delay disability in progressive MS.
The Central Vein Sign in Multiple Sclerosis Lesions Is Present Irrespective of the T2* Sequence at 3 T.

Pages